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Genome editing of avian species:
implications for animal use and welfare
Sudeepta K Panda and Mike J McGrew
Abstract
Avian species are used as model systems in research and have contributed to ground-breaking concepts in
developmental biology, immunology, genetics, virology, cancer and cell biology. The chicken in particular is
an important research model and an agricultural animal as a major contributor to animal protein resources
for the global population. The development of genome editing methods, including CRISPR/Cas9, to mediate
germline engineering of the avian genome will have important applications in biomedical, agricultural and
biotechnological activities. Notably, these precise genome editing tools have the potential to enhance avian
health and productivity by identifying and validating beneficial genetic variants in bird populations. Here, we
present a concise description of the existing methods and current applications of the genome editing tools in
bird species, focused on chickens, with attention on animal use and welfare issues for each of the techniques
presented.
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Introduction
Genome editing (GE) is a method for the rapid intro-
duction of precise changes into an organism’s genome.
GE tools consist of programmable site-specific nucle-
ases, that is meganucleases, zinc finger nucleases,
TALENs, and CRISPR/Cas9.1,2 All of these program-
mable site-specific nucleases or ‘genome editors’ can be
used to efficiently create precise genetic changes, gen-
erated through double-stranded breaks (DSBs) at spe-
cific locations in the genome. The DSBs are repaired by
two conserved cellular machinery pathways: the non-
homologous end-joining (NHEJ) pathway or the rarer
homology-directed repair (HDR) pathway. The NHEJ
pathway is often used by the cell to repair DNA
damage and can result in small genetic insertions or
deletions (INDELs) at the DSB. The more accurate
HDR pathway occurs in the presence of a sister chro-
matid or an exogenous DNA fragment containing a
homologous region spanning the DSB which are used
as templates to repair the DSB.3 The HDR repair pro-
cess has been exploited to generate defined small genet-
ic deletions, insertions, single base-pair changes in a
gene, and even the directed integration of large
exogenous transgenes precisely into the host cellular
genome. What is novel is that this technology enables
the creation of site-specific genetic changes without
leaving any other modifications in the genome (foot-
printless editing), and these changes are indistinguish-
able from naturally occurring genetic variants. The
development of genome targeting through HDR has
significantly improved ‘transgenic’ research, by creat-
ing both plant and animal models with more precise
and defined manipulations of the genome.
Avians serve as an important source of animal pro-
tein, and as a research model for the study of develop-
mental biology, immunology and infectious diseases.4
The chicken is both the principal avian research model
and an agricultural animal with a global population
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numbering over 60 billion animals annually.
Commercial chicken flocks are the source of fertile
eggs for many experiments and these eggs can also be
for public food consumption. Specialised chicken
research flocks are also maintained at research insti-
tutes in compliance with the Animals (Scientific
Procedures) Act 1986 in the UK and these flocks
have been selectively bred to have defined genetic resis-
tances and susceptibilities to avian diseases, specific
developmental genetic mutations, or have been geneti-
cally modified to carry exogenous transgenes. Many
other bird species such as quail, duck and zebra finch
are also used as standard laboratory research models.5
The annual Statistics of Scientific Procedures on Living
Animals Great Britain 2019 reported 0.13 million
avians (8%) among all animal groups were used in
experimental procedures, whilst only 0.1% of birds
were used for the creation and breeding of genetically
altered (GA) animals.6
Avian flocks are susceptible to a plethora of bacte-
rial and viral pathogens threatening their health and
welfare, and directly threatening flock security and
the global agro-economy.7 Bacterial pathogens such
as Campylobacter jejuni and Salmonella enteritidis
cause health risks from raw poultry products and con-
sequently cause foodborne illness in humans.8 Viral
pathogens causing Newcastle Disease and Marek’s
Disease are impactful on both wild birds and the poul-
try industry9 and the avian influenza A virus (IAV)
creates both animal and public health concerns.10 GE
avian models to investigate disease-resistance are of
special interest to the poultry industry. GE avian
research models to address key unanswered questions
in developmental biology, immunology, physiology,
cell biology and neural biology are also important to
life scientists. Chicken eggs have also been used for the
production of biopharmaceutical products.12 This
review will focus on advances of GE tools in the chick-
en, which is the most developed avian research species,
and highlight advances made in other avian species.
GE of bird species
Mammalian assisted invitro reproductive technologies
are well developed and mimic invivo reproductive phys-
iology. They are based on synchronisation and super-
ovulation of the donor animal followed by oocyte
retrieval, invitro fertilisation or cloning and subsequent
re-implantation into a surrogate host female (Figure 1
(a)). The one-cell fertilised zygote serves as an accessi-
ble recipient for the microinjection of genome editors
to create specific genetic alterations. Gordon and
Ruddle first reported the pronuclear microinjection
method by directly delivered the exogenous DNA
into the nucleus of the zygote.13 Pronuclear
microinjection leads to the random integration of the
exogenous DNA that can result in high mosaicism and
aberrant transgene expression. Scientists spent decades
refining and adopting this technology to other mam-
malian species such as rabbit, pig, sheep, goat and
cattle.14–16 Genome editors can similarly be introduced
into the cytoplasm or the pronuclei of the zygote. The
genetic changes created in the early stage embryo are
carried to the successive developmental stages to gen-
erate mosaic founder animal that will contain the
genetic change in some or all of its cells, including the
reproductive germ cells. Targeted genome edited
somatic cells can also be used as a nuclear donor in
enucleated oocytes in the process of somatic cell nucle-
ar transfer (SCNT) or hand-made cloning17,18 to pro-
duce live offspring carrying the desired genome edit in
all cells of the animal. This two-step protocol, editing
of somatic cells followed by SCNT, has proven to be
efficient and highly precise to create specific alterations
to the livestock genome in a single generation without
the need for breeding multiple generations to obtain
homozygous animals containing the desired edit.
However, limitations of this technique include the dif-
ficulty in targeting somatic cells, low cloning efficien-
cies and large offspring syndrome with its associated
birth complications.19 Even with these caveats, genome
editing using SCNT has been accomplished in pig,
cattle, goat and sheep species.20–23
In contrast to mammalian species, avians have a
unique reproductive physiology as well as distinctive
structure of the ovum and pre-gastrulation stage
embryo. In birds, the macrolecithal ovum is released
from the ovary surrounded by a tough vitelline mem-
brane, which serves as a protective layer around the
deposited yolk. The ovulated ovum is rapidly fertilised
with sperm that is stored by the female in sperm glands
located in the oviduct. The single-cell zygote consists of
a small pool of cytoplasm containing the fused pronu-
clei on the surface of the large yolk mass. The zygote
takes approximately 24 h to pass through the oviduct
region; the egg white is first added to enclose the yolk,
followed by a shell membrane and a hard shell that are
added during the final stages of passage through the
oviduct. During this journey of the zygote from infun-
dibulum to cloaca for laying of the egg, the single-cell
zygote has undergone multiple rounds of cleavage and
the pool of cytoplasm has developed into the blasto-
derm layer consisting of many tens of thousands of
undifferentiated cells. Subsequently, the laid egg can
be artificially or naturally incubated until hatching
(Figure 1(b)). Thus, the relatively simple straightfor-
ward one-cell embryo microinjection procedures of
generating genome edited mammalian embryos or
SCNT cannot be easily replicated in birds as the early
stage embryo is not accessible. Recent advances,
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however, have been made manipulating the early stage
of ovum using intracytoplasmic sperm injection (ICSI)
for fertilisation24 and a surrogate shell for incubation.25
However, this ICSI method has yet to be used for GE
as few hatchlings were obtained from the ICSI
embryos.
Mouse and human embryonic stem cells (ES cells),
derived from the blastocyst stage embryo, are useful
cell lines as they can be genetically modified in vitro
and can be differentiated into any cell type of the
body. Mouse ES cells will also contribute to embryonic
chimeras and form functional sperm or eggs. Avian ES
cells cultured from the avian blastoderm of laid eggs
(Figure 1(b)) have been propagated for chicken.26
However, similar to other livestock species, no evidence
of germline transmission using cultured (longer than
one week) embryonic stem cells has been reported for
chicken or other bird species. Instead, chicken ES cells
injected into early chicken embryos contributed to
somatic tissue but not to the germline after only a
short period of invitro culture.26,27 This may be because
the germ cell lineage, cells that are destined to
form sperm and oocytes, are present and segregated
as a  50 cell population in the blastoderm of the
laid avian egg. This is very different from mammalian
species for which the germ cell lineage forms much later
in embryonic development. This also signifies that the
delivery of GE tools needs to target this small popula-
tion of germ cells in avian species to order to achieve
genetic transmission to the offspring of the injected
animal.
Methods used for CRISPR/Cas9-mediated
in-ovo GE in birds
In spite of the complex architecture of the avian zygote,
researchers have developed several delivery methods to
introduce genetic vectors into the early avian embryo
and cells from the embryo. As CRISPR/Cas9 genome
editors are proving highly efficient at modifying the
target species genome, these vectors are revolutionising
efforts to manipulate the genome of birds. Current
delivery methods to avian embryos and gametes are
shown in Figure 2.
Direct electroporation of embryos
The advantage of the avian model is that the develop-
ing avian embryo is directly accessible through a hole
made in the surrounding egg shell, in a process called
‘windowing the egg’. The shell can be resealed and the
egg re-incubated until the desired embryonic stage is
reached or the embryo can be hatched. Direct in ovo
electroporations of CRISPR/Cas9 plasmids into the
embryo can lead to GE of the electroporated
Figure 1. Schematic diagram of the reproductive physiology of bovine and chicken species. (a) Production of high genetic
merit calves through the process of the synchronisation, superovulation, ovum pick up, in vitro fertilization or cloning, and
embryo transfer to the surrogate cow. (b) Reproductive cycle of chicken through the process of natural mating or artificial
insemination followed by incubation, hatching and raising to sexual maturity.
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embryo.28–30 In an improvement of this technique,
Bartsch et al. combined Cas9 transgenic chicken
embryos with the in ovo electroporation of guide
RNAs, demonstrating in ovo electroporation in the
chicken embryo is a feasible method of generating
inovo GE chickens.31 Similar experiments carried out
in mammalian species require surgery for the in utero
manipulations of the embryo with concomitant
increased welfare impacts on the mother. Thus, the
use of avian embryos represents a refinement by reduc-
ing the number of animals used and carrying out
experiments at unprotected stages.
Blastoderm injection
Several research groups contributed the first genetically
modified chickens using blastoderm injection of viral
vectors.32 A small cavity lies under the blastoderm, the
‘subgerminal cavity’, into which viral vectors can be
introduced which will then transduce the overlying
blastodermal cells and blastodermal germ cells
(Figure 2(a)). The first genetically modified chicken
was generated by the integration of the retroviral
vector, known as avian leucosis virus (ALV), into the
germline after blastoderm injection.33 Later, the effi-
cient generation of genetically modified chickens was
reported using various replication-deficient viral vec-
tors.34–36 Our laboratory and others showed an
improved germline transmission of transgenes in chick-
en, quail and zebra finch using lentiviral-based vec-
tors.36–39 Recently, adenoviruses were used to deliver
a Cas9 transgene and a guide RNA directly to the quail
blastoderm.40,41 Initially, authors targeted the quail
melanophilin gene, resulting in grey plumage of homo-
zygous GE quail offspring produced from the founder
birds, whereas heterozygous and wild type quail exhib-
ited dark brown plumage.40 In 2020, the same labora-
tory targeted the quail myostatin gene, generated
germline chimera and offspring. Homozygous myosta-
tin edited quail showed significantly enhanced body
Figure 2. Schematic representation of different possible methods of establishing genome edited (GE) chicken. (a–e) the
workflow of GE in the chicken via transduction with GE reagents to the embryonic blastoderm of a laid egg chicken
embryo (a), sperm transfection for artificial insemination (b), primordial germ cell (PGC) transfection in ovo of embryos
(c), PGC transfection in vitro culture (d), and transfer of in vitro GE PGCs to sterile host and subsequent mating of sterile
G0 founders to generate pure GE chicken (e). After Looi et al.64
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weight and muscle mass.41 In spite of the success of
virus-mediated GE in quails and the feasibility of
applying this delivery method of genome editors to
other avian species, the efficiency of this virus-
mediated method is low because of the low efficacy
of transducing the blastodermal primordial germ cells
after viral injection into the subgerminal cavity. In
addition, increasing the size of lentiviral vectors to
introduce Cas9 and the RNA guide leads to inefficient
viral packaging that results in a low viral titer and
reduced transduction efficacy. Similarly, windowing
avian eggs for injection of virus followed by the subse-
quent hatching of chicks, will have varying survivabil-
ity in different bird species.
Embryonic vascular system injection
A method for producing both genetically modified
chicken and quail is by the direct injection of Tol2
transposon vectors into the vascular system of young
embryos to target the germ cells during their migration
through the circulation (Figure 2(c)).42,43 Transposons
are self-integrating DNA vectors that can carry a trans-
genic cargo within the vector. Serralbo et al. succeeded
in producing many fluorescent reporter lines of trans-
genic quail using this technique.44 A limitation of this
technique is that the transmission rate (frequency of
producing GE offspring) is  1%. Recently,
Challagulla et al. reported an inovo delivery of GE
components such as TALENs and CRISPR/Cas9,
known as ‘invivo transfection of PGCs [primordial
germ cells]’, into the bloodstream of early embryos to
generate GE offspring.45 A limitation of this technique
is the low germline transmission rate,  0.3%. Though
this method indicates that the direct genome editing of
any avian species is theoretically possible, the low
transmission rate due to the low efficiency of genetical-
ly modifying the migratory PGCs in the vascular
system and the resulting stable integration of the
Cas9 vectors into the genome of the injected animal
are drawbacks of this technique.
In vitro propagated avian PGCs
As stated above, germline-competent ES cells have not
been isolated in avian species, which can be attributed
to the early segregation of the germ cell lineage from
the somatic cell lineage in birds. As is true for all ver-
tebrate species, PGCs of birds are the progenitors or
precursor cells of the sperm and oocytes. In freshly laid
chicken eggs, as mentioned above, there are approxi-
mately 50 PGCs located within the centre of the blas-
toderm which contains approximately 40,000–60,000
cells.46 Subsequently, PGCs migrate to the anterior ger-
minal crescent from where 100–200 PGCs enter the
embryonic circulatory system at 48–60 h of incubation
before migration to the forming gonad. PGCs will
undergo sexual differentiation into spermatogonial
stem cells in the male, producing spermatozoa. In
females, PGCs undergo meiosis and will form mature
oocytes upon sexual maturity.47 In striking contrast to
mammals, PGCs from chicken embryos can be isolated
and cultured indefinitely, while keeping their commit-
ment to the germline and germline competency.48
Chicken PGCs are extracted from the vascular system
at early developmental stages and placed in culture.49
A defined serum-free culture medium for propagating
chicken PGCs has been developed by optimising the
signalling pathways necessary for avian germ cell self-
renewal.50
The long-term culture of PGCs does not compro-
mise their ability to colonise the gonad when injected
into the vascular system of surrogate host embryos and
form functional gametes and offspring when the surro-
gate hosts are subsequently bred. This has been a turn-
ing point for the generation of GE chicken models
through GE of culture PGCs (Figure 2(d) and (e)).51
Numerous reports based on using PGCs for the gener-
ation of GE chickens have been published including
homologous recombination,52 TALENs,53,54 and
CRISPR/Cas9 system.55,56 Among the genome editors,
CRISPR/Cas9 has been successfully used in PGCs in
developing functional genetic models by generating
immunoglobulin heavy chain transgenic chicken,55
ovomucoid KO chicken56 and myostatin KO chicken.57
Using cultured PGCs, a demonstration of GE for
avian disease resistance has been achieved. Acidic
nuclear phosphoprotein 32 family member A
(ANP32A) was recently identified as a cellular host
protein in birds required for avian influenza virus
(IAV) polymerase adaptation and activity.58 Long
et al. used CRISPR/Cas9 to knock out the ANP32A
in chicken PGCs, demonstrated that fibroblasts derived
from GE PGCs did not support either mammalian or
avian influenza virus polymerase activity during invitro
challenge experiments and were resilient to IAV infec-
tion.59 Similarly, Koslová et al. and Hellmich et al.
used CRISPR/Cas9 to delete the tryptophan residue
number 38 of the Naþ/Hþ exchanger type 1 gene in
PGCs, which is a critical amino acid for the entry of
ALV subgroup J (ALV-J). The subsequent chickens gen-
erated from the GE PGCs were ALV-J resistant in in-
vitro and invivo challenge experiments.60,61 The frequency
of generating GE offspring from embryonic injections of
GE PGCs is variable and usually from 1–50%.
Sperm mediated GE
Cooper et al. demonstrated that spermatozoa can be
directly transfected and targeted with CRISPR/Cas9
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GE tools.62 Subsequently, the GE sperm can be used
for artificial insemination. This process is called sperm
assisted gene editing (STAGE) and has been used to
make GE chickens in a single generation (Figure 2(b)).
However, the drawbacks of this technique are the
genetic deletions in the offspring did not closely corre-
spond to the cleavage site of the CRISPR/Cas9 in the
genome and the rate of genetic modification in the off-
spring from the founders was from 0–26%.62
The above results show that genetic modification of
chicken and quail is highly advanced. A comprehensive
list of genetically modified chicken and quail available
in different research laboratories are reported in other
reviews.44,63
Use of avian sterile hosts to address the
principles of the 3Rs
A key challenge for GE of bird species is to efficiently
produce GE offspring from the mosaic founder or sur-
rogate hosts without breeding hundreds of non-GE off-
spring. Until now, the most successful method of
generating genome edited chickens is by injecting exog-
enous edited PGCs intravenously into stage 15–16þ
HH (Hamburger Hamilton) surrogate embryo in win-
dowed eggs. However, the edited donor PGCs and
endogenous PGCs compete with each other to form
functional gametes. Thus, there is a greater opportuni-
ty for the endogenous PGCs to transmit its genome to
the subsequent generation of offspring than the donor
PGCs. To expedite the germline transmission from the
donor edited PGCs, endogenous PGCs can be eliminat-
ed by busulfan and c-irradiation, both of which can
cause death and health problems for the treated host
bird.65,66 However, GE can be used to create gene
knockouts to eliminate the competition from endoge-
nous PGCs by rendering the host bird devoid of sperm
or eggs. Two sterile chicken host models have been
produced: a TALEN-mediated knockout of the germ
cell determinant, DDX4 (DEAD-Box helicase 4) which
resulted in sterile hens, and CRISPR/Cas9 insertion of
an inducible transgene insertion (iCaspase9) which gen-
erated sterile cockerels and hens. Both models trans-
mitted only donor PGCs to the next generation
offspring.53,54,67 Remarkably, the direct mating of G0
sterile host cockerels and hens carrying GE donor
PGCs leads to the generation of pure GE offspring in
one generation. This technique is described as ‘sire dam
surrogate mating’ (Figure 2(e)). Thus, sterile chicken
surrogate hosts aid in the generation of GE birds
using a reduced number of animals, thus supporting
3Rs principles, and is potentially applicable in projects
for the ‘cryoconservation’ of poultry and endangered
avian breeds.
The future for GE in other avian species
The injection of GE reagents directly into the blood-
stream of embryonated eggs through a window made in
the egg shell can theoretically be applied to all bird
species. However, this technique is inefficient for the
generation of transgenic and GE offspring (0.3–1%)
and the hatch rate of the windowed injected eggs
will differ drastically between bird species.68,69
Transmission rates of the genetic modification using
this technique are currently low in chicken and multiple
generations will be needed to generate pure offspring
containing a homozygous GE allele. These methods
will prove more difficult when applied to other avian
model species such as zebra finch, ducks and turkeys. It
would be extremely beneficial to be able to propagate
the PGCs in vitro for other avian species and to develop
sterile surrogate birds that would be appropriate hosts
for the germ cells from multiple species.70–72 It has been
demonstrated that male germ cells can form functional
gametes when transplanted between evolutionarily dis-
tant bird species such as chicken to duck, pheasant to
chicken, chicken to guinea fowl, and chicken to the
houbara bustard.68,73–75 Thus, it should be possible to
use a sterile chicken host for male genome modified
PGCs from any bird species. However, oocyte and
egg development has not been demonstrated after
PGC transplantation between bird species. The
oocyte size varies greatly between bird species and the
somatic granulosa cells that surround the oocyte con-
trol both oocyte maturation and ovulation. It remains
to be determined if hybrid follicles comprised of donor
germ cells from one bird species can form a functional
egg in another bird species.
Conclusions
The chicken has been a mainstay of vertebrate embryol-
ogy research for many decades because their embryos
come conveniently packaged in eggs and offer easy acces-
sibility of developmental stages for experimental manip-
ulations.11 Many fundamental questions yet have to
answer in developmental biology around neural develop-
ment, organogenesis and patterning of the embryo. The
advancement of the GE tools in chicken in combination
with live-cell imaging and single-cell transcriptomics in
both embryos and adult chicken has the potential of
exploring these pertinent questions. Transferring these
tools to other bird species would facilitate research
efforts in many laboratory settings.
The chicken is an invaluable model for studying
basic immunology and provides seminal contributions
to fundamental immunological principles such as graft-
versus-host responses and the key role of lymphocytes
in adaptive immunity.76 Infectious disease outbreaks in
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poultry is a persistent threat to the poultry sector as
well as concerns of zoonotic transmission. GE tools can
help to investigate disease-resistance in birds and also
heat tolerance to combat climate impact on poultry
production. In summary, the ongoing improvements
in genome modification tools with avian embryo
manipulation and PGC culture continues to refine the
production of GE avian species with positive outputs
on the 3R principles.
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Resume
Les especes aviaires sont utilisees comme systemes modeles dans la recherche et ont contribue à des
concepts revolutionnaires en matiere de biologie du developpement, d’immunologie, de genetique, de viro-
logie, de cancer et de biologie cellulaire. Le poulet en particulier est un modele de recherche important ainsi
qu’un un animal agricole constituant une source majeure de proteines animales pour la population mondiale.
Le developpement de methodes d’edition du genome, y compris CRISPR/Cas9, permettant de medier
l’ingenierie de lignee germinale du genome aviaire, aura des applications importantes dans les activites
biomedicales, agricoles et biotechnologiques. Ces outils precis d’edition du genome ont notamment le
potentiel d’ameliorer la sante et la productivite des oiseaux en identifiant et en validant les variantes
genetiques benefiques chez les populations d’oiseaux. Nous presentons ici une description concise des
methodes existantes et des applications actuelles des outils d’edition du genome chez les especes d’oiseaux,
axes sur les poulets, en mettant l’accent sur l’utilisation des animaux et les questions de bien-être pour
chacune des techniques presentees.
Abstract
Vogelarten dienen in der Forschung als Modellsysteme und haben zu bahnbrechenden Konzepten in der
Entwicklungsbiologie, Immunologie, Genetik, Virologie, Krebsforschung und Zellbiologie beigetragen.
Insbesondere das Huhn, das als Nutztier einen großen Beitrag zur Versorgung der Weltbev€olkerung mit
tierischem Protein leistet, ist ein wichtiges Forschungsmodell. Die Entwicklung von Genome-Editing-
Methoden, darunter CRISPR/Cas9, für Keimbahn-Engineering des avi€aren Genoms wird zu wichtigen
Anwendungen in der Biomedizin, Landwirtschaft und Biotechnologie führen. Insbesondere haben diese
pr€azisen Genome-Editing-Tools das Potenzial, die Gesundheit und Produktivit€at von V€ogeln zu verbessern,
indem vorteilhafte genetische Varianten in Vogelpopulationen identifiziert und validiert werden. Hier
pr€asentieren wir eine kurze Beschreibung der existierenden Methoden und aktuellen Anwendungen der
Genome-Editing-Tools bei Vogelarten, wobei der Schwerpunkt auf Hühnern liegt. Besonderes Augenmerk
gilt Fragen der Tiernutzung und des Tierschutzes für die einzelnen vorgestellten Techniken.
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Resumen
Las especies aviares se utilizan como sistemas de modelos de animales para la investigacion y han contrib-
uido en conceptos innovadores de la biologıa del desarrollo, en la inmunologıa, la genetica, la virologıa, la
lucha contra el cáncer y la biologıa celular. El pollo es especialmente un modelo de investigacion y animal
agrıcola de gran importancia ya que representa un gran contribuidor para las fuentes de proteınas de
animales para la poblacion global. El desarrollo de los metodos de edicion genomica, incluido CRISPR/
Cas9, para mediar la ingenierıa la lınea germinal del genoma aviar tendrá aplicaciones importantes en las
distintas actividades biomedicas, agrıcolas y biotecnologicas. En especial, estas herramientas de edicion
genomica precisas tienen el potencial de mejorar la productividad y la salud aviar identificando y validando
variantes geneticas beneficiosas en las poblaciones aviares. En este estudio presentamos una descripcion
concisa de los metodos existentes y las aplicaciones actuales de las herramientas de edicion genomica en
especies aviares, centrándonos en pollos y prestando atencion al uso y el bienestar animal para cada una de
las tecnicas presentadas.
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